Diagnostic delays among COVID‐19 patients with a second concurrent diagnosis
Journal of Hospital Medicine · 2023
DOI: 10.1002/jhm.13063 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Hospital Medicine, 2023. Verfasst von Ophir Freund und 9 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine B, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Delayed Diagnosis, COVID-19. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Little is known about the effect of a new pandemic on diagnostic errors.
Objective
We aimed to identify delayed second diagnoses among patients presenting to the emergency department (ED) with COVID‐19. Designs An observational cohort Study. Settings and Participants Consecutive hospitalized adult patients presenting to the ED of a tertiary referral center with COVID‐19 during the Delta and Omicron variant surges. Included patients had evidence of a second diagnosis during their ED stay. Main Outcome and Measures The primary outcome was delayed diagnosis (without documentation or treatment in the ED). Contributing factors were assessed using two logistic regression models.
Results
Among 1249 hospitalized COVID‐19 patients, 216 (17%) had evidence of a second diagnosis in the ED. The second diagnosis of 73 patients (34%) was delayed, with a mean (SD) delay of 1.5 (0.8) days. Medical treatment was deferred in 63 patients (86%) and interventional therapy in 26 (36%). The probability of an ED diagnosis was the lowest for Infection‐related diagnoses (56%) and highest for surgical‐related diagnoses (89%). Evidence for the second diagnosis by physical examination (adjusted odds ratios [AOR] 2.35, 95% confidence interval [CI] 1.20–4.68) or by imaging (AOR 2.10, 95% CI 1.16–3.79) were predictors for ED diagnosis. Low oxygen saturation (AOR 0.38, 95% CI 0.18–0.79) and cough or dyspnea (AOR 0.48, 95% CI 0.25–0.94) in the ED were predictors of a delayed second diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Internal Medicine B, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Emergency Department, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
ORCID-Profile: Ophir Freund
Zitieren
APA
Freund, O., Azolai, L., Sror, N., Zeeman, I., Kozlovsky, T., Greenberg, S. A., Epstein Weiss, T., Bornstein, G., Tchebiner, J. Z., & Frydman, S. (2023). Diagnostic delays among COVID‐19 patients with a second concurrent diagnosis. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.13063
Vancouver
Freund O, Azolai L, Sror N, Zeeman I, Kozlovsky T, Greenberg SA, et al. Diagnostic delays among COVID‐19 patients with a second concurrent diagnosis. Journal of Hospital Medicine. 2023. doi:10.1002/jhm.13063
BibTeX
@article{Freund2023,
author = {Freund, Ophir and Azolai, Lee and Sror, Neta and Zeeman, Idan and Kozlovsky, Tom and Greenberg, Sharon A and Epstein Weiss, Tali and Bornstein, Gil and Tchebiner, Joseph Zvi and Frydman, Shir},
title = {Diagnostic delays among COVID‐19 patients with a second concurrent diagnosis},
journal = {Journal of Hospital Medicine},
year = {2023},
doi = {10.1002/jhm.13063}
}
EUVIMED